EIRGENIX INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 84.5 TWD | -2.09% |
|
+5.62% | -15.92% |
| May. 15 | EirGenix Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 22 | EirGenix Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 4,647 | 9,700 | 33,476 | 37,428 | 30,748 | 25,683 | - |
| Enterprise Value (EV) 1 | 5,338 | 9,800 | 26,978 | 31,421 | 25,815 | 21,579 | 23,243 |
| P/E ratio | -5.09 x | -8.69 x | -619 x | -324 x | -33.5 x | -84.5 x | -34.8 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | 9.76 x | 9.05 x | 19.7 x | 25.3 x | 30.1 x | 15.7 x | 17.4 x |
| EV / Revenue | 11.2 x | 9.14 x | 15.9 x | 21.2 x | 25.2 x | 13.2 x | 15.8 x |
| EV / EBITDA | -7.27 x | -12 x | 220 x | -243 x | -32.5 x | 34.4 x | - |
| EV / FCF | -4.48 x | -21.4 x | -137 x | -63.7 x | -18.1 x | 379 x | -14 x |
| FCF Yield | -22.3% | -4.67% | -0.73% | -1.57% | -5.52% | 0.26% | -7.16% |
| Price to Book | 2.51 x | 5.09 x | 3.21 x | 3.5 x | 3.07 x | 2.66 x | - |
| Nbr of stocks (in thousands) | 169,284 | 206,375 | 300,232 | 304,290 | 305,946 | 306,109 | - |
| Reference price 2 | 27.45 | 47.00 | 111.5 | 123.0 | 100.5 | 84.50 | 84.50 |
| Announcement Date | 3/29/20 | 3/25/21 | 3/30/22 | 3/20/23 | 3/22/24 | - | - |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 476.1 | 1,072 | 1,697 | 1,481 | 1,023 | 1,639 | 1,472 |
| EBITDA 1 | -734 | -813.9 | 122.4 | -129.2 | -793.1 | 628 | - |
| EBIT 1 | -847.7 | -986 | -60.52 | -333.4 | -1,032 | -519 | -883 |
| Operating Margin | -178.05% | -91.99% | -3.57% | -22.51% | -100.91% | -31.67% | -59.99% |
| Earnings before Tax (EBT) 1 | -860.9 | -1,041 | -42.39 | -115.2 | -913.6 | -306 | -745 |
| Net income 1 | -860.9 | -1,042 | -42.58 | -115.5 | -915.2 | -307 | -745 |
| Net margin | -180.83% | -97.19% | -2.51% | -7.8% | -89.49% | -18.73% | -50.61% |
| EPS 2 | -5.390 | -5.410 | -0.1800 | -0.3800 | -3.000 | -1.000 | -2.430 |
| Free Cash Flow 1 | -1,192 | -457.4 | -196.6 | -493.3 | -1,424 | 57 | -1,664 |
| FCF margin | -250.4% | -42.68% | -11.58% | -33.31% | -139.23% | 3.48% | -113.04% |
| FCF Conversion (EBITDA) | - | - | - | - | - | 9.08% | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 3/29/20 | 3/25/21 | 3/30/22 | 3/20/23 | 3/22/24 | - | - |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 423.5 | 361.5 | 336.6 | 361.6 | 421.3 | 216.3 | 138.3 | 211.5 | 456.6 | 219.7 | 223 | 257 | 940 | 291 | 354 |
| EBITDA 1 | 54.15 | 12.95 | -35.58 | -89.36 | -17.24 | -162.9 | -198.3 | -141.4 | - | -141 | 118 | 156 | 512 | - | - |
| EBIT 1 | 7.657 | -35.19 | -85.45 | -141.8 | -71.01 | -220.5 | -255.9 | -199.4 | -356.2 | -214 | -248 | -320 | 263 | -331 | -241 |
| Operating Margin | 1.81% | -9.73% | -25.39% | -39.2% | -16.85% | -101.91% | -185.03% | -94.29% | -78.02% | -97.42% | -111.21% | -124.51% | 27.98% | -113.75% | -68.08% |
| Earnings before Tax (EBT) 1 | 2.182 | 14.19 | 6.787 | -27.16 | -109 | -203.2 | -193.6 | -111.3 | -405.5 | -103.6 | -215 | -285 | 297 | -296 | -180 |
| Net income 1 | 3.094 | 13.85 | 6.418 | -27.56 | -108.2 | -203.5 | -194.1 | -111.7 | -405.9 | -104 | -215 | -285 | 297 | -180 | -159 |
| Net margin | 0.73% | 3.83% | 1.91% | -7.62% | -25.69% | -94.07% | -140.3% | -52.84% | -88.91% | -47.35% | -96.41% | -110.89% | 31.6% | -61.86% | -44.92% |
| EPS 2 | 0.0200 | 0.0500 | 0.0200 | -0.0900 | -0.3600 | -0.6700 | -0.6400 | -0.3700 | -1.330 | -0.3400 | -0.7000 | -0.9300 | 0.9700 | -0.9700 | -0.5900 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/30/22 | 5/13/22 | 8/12/22 | 11/11/22 | 3/20/23 | 5/15/23 | 8/9/23 | 11/13/23 | 3/22/24 | 5/15/24 | - | - | - | - | - |
1TWD in Million2TWD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | 691 | 100 | - | - | - | - | - |
| Net Cash position 1 | - | - | 6,498 | 6,006 | 4,933 | 4,104 | 2,440 |
| Leverage (Debt/EBITDA) | -0.941 x | -0.1233 x | - | - | - | - | - |
| Free Cash Flow 1 | -1,192 | -457 | -197 | -493 | -1,424 | 57 | -1,664 |
| ROE (net income / shareholders' equity) | -43.7% | -55.4% | -0.69% | -1.09% | -8.84% | -3.2% | -8.3% |
| ROA (Net income/ Total Assets) | -26.9% | -28.7% | -0.56% | -0.99% | -7.96% | -2.8% | -7% |
| Assets 1 | 3,197 | 3,626 | 7,638 | 11,644 | 11,505 | 10,964 | 10,643 |
| Book Value Per Share 2 | 11.00 | 9.230 | 34.70 | 35.10 | 32.70 | 31.80 | - |
| Cash Flow per Share 2 | -4.630 | -2.180 | -0.1300 | -0.4900 | - | 1.320 | - |
| Capex 1 | 408 | 38.1 | 167 | 346 | 575 | 301 | 1,214 |
| Capex / Sales | 85.71% | 3.56% | 9.82% | 23.35% | 56.25% | 18.36% | 82.47% |
| Announcement Date | 3/29/20 | 3/25/21 | 3/30/22 | 3/20/23 | 3/22/24 | - | - |
1TWD in Million2TWD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
84.5
TWD
Average target price
112.5
TWD
Spread / Average Target
+33.14%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -15.92% | 802M | |
| +0.46% | 91.38B | |
| -2.37% | 38.68B | |
| +71.67% | 27.84B | |
| -12.31% | 16.05B | |
| -4.54% | 13.48B | |
| -10.83% | 11.73B | |
| +180.20% | 10.74B | |
| -48.60% | 10.39B | |
| +1.35% | 8.94B |
- Stock Market
- Equities
- 6589 Stock
- Financials EirGenix Inc.
